Delivery Order SPE2DB22D1106-SPE2DB24FEFH8
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,743.59, is a Delivery Order for "DIGIFAB 40 MG VIALS" and has a firm fixed price. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,573.38 Firm Fixed Price Delivery Order is for the supply of DIGIFAB 40 MG VIALS, a medical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,842.65, is for the delivery of 4567089245 DIGIFAB 40 MG VIALS and has an ultimate completion date of January 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,842.65, is for the supply of DIGIFAB 40 MG VIALS, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- This federal contract award, SPE2DB22D3009|SPE2DB25FAP25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $23,860.38, is for the delivery of DIGIFAB 40 MG VIALS and has a completion date of January 22, 2025. The contract is a Firm Fixed Price Delivery Order and was awarded on January 21, 2025. The contract does not have a set-aside designation, indicating...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,837.73, is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDZPJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,475.50 firm-fixed-price delivery order is for the supply of DIGIFAB 40 MG VIALS, a medical product, with a completion date of March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FQXU1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $15,083.90, is for the supply of 4566790385 ! DIGIFAB 40 MG VIALS. The contract has a firm fixed price and an ultimate completion date of December 24, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEFH8Delivery Order
This federal contract award with ID SPE2DB22D1106|SPE2DB24FEFH8 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product, with a firm fixed price and a ceiling value of $31,819.61. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 3/18/24 |